Traitements médicaux des cancers de voies biliaires: y a-t-il (enfin) des progrès ? : Cholangiocarcinome = Medical treatments of bile duct carcinoma: is there anything new? : CholangiocarcinomaCHAUFFERT, Bruno; JOLY, Jean-Paul.Hépato-gastro & oncologie digestive. 2013, Vol 20, Num 3, pp 198-204, issn 2115-3310, 7 p.Article

Augmentation de l'efficacité antitumorale des anthracyclines et de la mitoxantrone par l'amiodarone, la cinchonine et l'encapsulation liposomale = Increase of aniracycline and mitoxanirone antitumor activity by amiodarone, cinchonine and iposomal encapsulationGenne, Philippe; Chauffert, Bruno.1992, 160 p.Thesis

Influcence of Localization of Primary Tumor on Effectiveness of 5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) in Patients with Metastatic Pancreatic Adenocarcinoma: A Retrospective StudyLORGIS, Veronique; CHAUFFERT, Bruno; GENTIL, Julie et al.Anticancer research. 2012, Vol 32, Num 9, pp 4125-4130, issn 0250-7005, 6 p.Article

Analysis of microsatellite instability in acquired drug-resistance human tumor cell linesPICARD, Samy-Felix; FRANCO, Noreli; SERGENT, Catherine et al.Oncology reports. 2002, Vol 9, Num 5, pp 971-976, issn 1021-335XArticle

Phase 2 study of intratumoral cisplatin and epinephrine treatment for locally recurrent head and neck tumorsDUVILLARD, Christian; ROMANET, Philippe; COSMIDIS, M. D et al.The Annals of otology, rhinology & laryngology. 2004, Vol 113, Num 3, pp 229-233, issn 0003-4894, 5 p.Article

Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)DAHAN, Laetitia; BONNETAIN, Frank; MICHEL, Pierre et al.Gut. 2010, Vol 59, Num 11, pp 1526-1534, issn 0017-5749, 9 p.Article

Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3⁺ Regulatory T CellsLADOIRE, Sylvain; ARNOULD, Laurent; APETOH, Lionel et al.Clinical cancer research. 2008, Vol 14, Num 8, pp 2413-2420, issn 1078-0432, 8 p.Article

High Pressure Enhances the Effect of Hyperthermia in Intraperitoneal Chemotherapy With Oxaliplatin: An Experimental StudyFACY, Olivier; SAMMAN, Sophieal; MAGNIN, Guy et al.Annals of surgery. 2012, Vol 256, Num 6, pp 1084-1088, issn 0003-4932, 5 p.Article

Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancerROYER, Bernard; DELROEUX, Delphine; GUARDIOLA, Emmanuel et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 3, pp 415-421, issn 0344-5704, 7 p.Article

Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteinsSERGENT, Catherine; FRANCO, Noreli; CHAPUSOT, Caroline et al.Cancer chemotherapy and pharmacology. 2002, Vol 49, Num 6, pp 445-452, issn 0344-5704Article

Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Federation Francophone de Cancérologie Digestive 9902 phase II randomised studyPHELIP, Jean-Marc; VENDRELY, Véronique; FAUCHART, Jean-Pierre et al.European journal of cancer (1990). 2014, Vol 50, Num 17, pp 2975-2982, issn 0959-8049, 8 p.Article

Bon usage du médicament dans les tumeurs solides : conformité à l'AMM et niveau de preuve scientifique = Appropriate cytotoxic drug usages in solid tumors : conformity to official labelling and level of scientific evidenceGRANGEASSE, Ludwig; COUDERT, Bruno; PIVOT, Xavier et al.Bulletin du cancer. 2006, Vol 93, Num 10, pp 1047-1054, issn 0007-4551, 8 p.Article

Réponse majeure d'un volumineux carcinome hépatocellulaire à une chimioembolisation par pirarubicine, amiodarone et Lipiodol® = Sustained clinical response of large hepatocellular carcinoma after chemoembolization with pirarubicin, amiodarone and Lipiodol®CERCUEIL, Jean-Pierre; FERRANT, Emmanuelle; ISAMBERT, Nicolas et al.Gastroentérologie clinique et biologique. 2004, Vol 28, Num 12, pp 1281-1283, issn 0399-8320, 3 p.Article

Saponins-mediated potentiation of cisplatin accumulation and cytotoxicity in human colon cancer cellsGAIDI, Ghezala; CORREIA, Maria; CHAUFFERT, Bruno et al.Planta medica. 2002, Vol 68, Num 1, pp 70-72, issn 0032-0943Article

Bidentatoside I, a new triterpene saponin from Achyranthes bidentataMITAINE-OFFER, Anne-Claire; MAROUF, Abderrazak; PIZZA, Cosimo et al.Journal of natural products (Print). 2001, Vol 64, Num 2, pp 243-245, issn 0163-3864Article

Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenibLOUANDRE, Christophe; EZZOUKHRY, Zakaria; GODIN, Corinne et al.International journal of cancer (Print). 2013, Vol 133, Num 7, pp 1732-1742, issn 0020-7136, 11 p.Article

Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancerGUIU, Boris; PETIT, Jean Michel; GHIRINGHELLI, François et al.Gut. 2010, Vol 59, Num 3, pp 341-347, issn 0017-5749, 7 p.Article

Attempts to improve locoregional chemotherapy for the prevention of colonic cancer liver metastasis in the ratBENOIT, Laurent; FAVOULET P, Patrick; ORTEGA-DEBALLON, Pablo et al.Gastroentérologie clinique et biologique. 2006, Vol 30, Num 8-9, pp 1019-1025, issn 0399-8320, 7 p.Article

High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosisESQUIS, Philippe; CONSOLO, David; RAT, Patrick et al.Annals of surgery. 2006, Vol 244, Num 1, pp 106-112, issn 0003-4932, 7 p.Article

Low urine osmolarity as a determinant of cisplatin-induced nephrotoxicityPOLYCARPE, Emmanuel; ARNOULD, Laurent; SCHMITT, Elise et al.International journal of cancer. 2004, Vol 111, Num 1, pp 131-137, issn 0020-7136, 7 p.Article

Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude miceFAVOULET, Patrick; BENOIT, Laurent; OSMAK, Liliana et al.World journal of surgery. 2004, Vol 28, Num 5, pp 451-456, issn 0364-2313, 6 p.Article